A scoring system to predict 5‐year mortality in patients diagnosed with laryngeal glottic cancer

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10045/77775
Información del item - Informació de l'item - Item information
Título: A scoring system to predict 5‐year mortality in patients diagnosed with laryngeal glottic cancer
Autor/es: Jover-Esplá, Ana Gabriela | Palazón Bru, Antonio | Folgado-de la Rosa, David M. | Juan Herrero, Joaquín de | Gil Guillén, Vicente
Grupo/s de investigación o GITE: Biotecnología
Centro, Departamento o Servicio: Universidad de Alicante. Departamento de Biotecnología
Palabras clave: Glottis | Laryngeal neoplasms | Mobile applications | Models | Statistical | Mortality
Área/s de conocimiento: Biología Celular
Fecha de publicación: jul-2018
Editor: John Wiley & Sons
Cita bibliográfica: European Journal of Cancer Care. 2018, 27(4): e12860. doi:10.1111/ecc.12860
Resumen: Only one prognostic model for laryngeal cancer has been published, but it has not been properly validated and is only applicable to patients treated with radiotherapy. Consequently, we constructed, internally validated and implemented in an App (Android), a predictive model of 5‐year mortality in patients with glottic cancer in a cohort study of 189 patients with glottic cancer in 2004–2016 in Spain. The main variable was time‐to‐death. Secondary variables were age, gender, TNM, stage, smoking, alcohol consumption, histology and treatment. A scoring system to predict mortality at 5 years was constructed, validated internally by bootstrapping and then integrated into an Android app. In all, 70 patients died (37.0%, 76 deaths per 1,000 patient‐years). The predictive model had the following prognostic factors: larger tumour size, greater degree of lymph node metastasis, higher stage, smoking and alcohol consumption. The internal validation of the model through bootstrapping was satisfactory. In conclusion, a points system to predict mortality at 5 years in patients with glottic cancer has been constructed, internally validated and integrated into an Android application. External validation is suggested to make available a quick and simple tool to establish the prognosis for these patients.
URI: http://hdl.handle.net/10045/77775
ISSN: 0961-5423 (Print) | 1365-2354 (Online)
DOI: 10.1111/ecc.12860
Idioma: eng
Tipo: info:eu-repo/semantics/article
Derechos: © 2018 John Wiley & Sons Ltd
Revisión científica: si
Versión del editor: https://doi.org/10.1111/ecc.12860
Aparece en las colecciones:INV - GIDBT - Artículos de Revistas

Archivos en este ítem:
Archivos en este ítem:
Archivo Descripción TamañoFormato 
Thumbnail2018_Jover-Espla_etal_EurJCancerCare_final.pdfVersión final (acceso restringido)458,95 kBAdobe PDFAbrir    Solicitar una copia


Todos los documentos en RUA están protegidos por derechos de autor. Algunos derechos reservados.